Jasper Therapeutics (JSPR)
(Real Time Quote from BATS)
$2.90 USD
-0.08 (-2.69%)
Updated Aug 6, 2025 11:00 AM ET
2-Buy of 5 2
D Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Jasper Therapeutics, Inc. has a market cap of $44.77M, which represents its share price of $2.98 multiplied by its outstanding shares number of 15.02M. As a small-cap company, JSPR's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
JSPR 2.90 -0.08(-2.69%)
Will JSPR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for JSPR based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for JSPR
Jasper Therapeutics (JSPR) Restructures to Focus on Briquilimab Development | JSPR Stock News
Jasper Therapeutics Announces Corporate Reorganization and Other Cost Cutting Measures to ...
Jasper Therapeutics to reduce workforce by 50%, focus on Chronic Urticaria
JSPR: Jasper Therapeutics Faces Major Price Target Adjustment | JSPR Stock News
Evercore ISI Group Lowers Price Target for Jasper Therapeutics (JSPR) | JSPR Stock News